ChargePoint Technology expands smart monitoring technology into North America

23 Jan 2019

Company's VERIFI smart monitoring hub allows production teams to manage and maintain their containment solution which, in turn, helps assure operator safety and sterility assurance related performance during pharmaceutical manufacturing processes.

Powder containment and sterile transfer solutions provider, ChargePoint Technology has achieved HazLoc (Hazardous Area) certification for VERIFI to further support customers in North America.

ChargePoint Technology expands smart monitoring technology into North America

The HazLoc certification has been granted by the Canadian Standards Association (CSA) and will enable ChargePoint to expand its VERIFI smart monitoring hub into the North American market.

The VERIFI smart monitoring hub is a first-of-its-kind technology which monitors usage of ChargePoint’s split butterfly valve (SBV), used to provide containment during pharmaceutical manufacturing.

VERIFI continuously records valve-use providing data that allows production teams to manage and maintain their containment solution in a proactive and efficient manner. In turn, this helps assure operator safety and sterility assurance related performance during pharmaceutical manufacturing processes.

Chris Rombach, president at ChargePoint Technology commented: “Having seen the positive impact and excellent response to VERIFI in European markets, we are proud to bring VERIFI to North America. We can now give our customers more autonomy to improve operational performance and productivity, as well as helping them manage risk in their manufacturing processes.”

ChargePoint Technology has worked closely with CSA over the last two years to achieve the certification for Class 1 Zone 0 and Class II/III Zone 21, which was granted after an inspection of the company’s Liverpool, UK manufacturing headquarters in late 2018.

The company already holds Atmosphere Explosive (ATEX) and International Electro Commission (IEC) Explosive (Ex) certifications, allowing the use of VERIFI in hazardous environments in Europe.

Adam Bunyard, director of innovation and technology at ChargePoint Technology said: “Our customer base in the North American market is rapidly growing and we are excited to now be able to support existing and future customers with our unique smart monitoring technology.

“As the industry moves towards Industry 4.0, ChargePoint will remain at the forefront of contained transfer innovation, responding to the challenges of today and tomorrow.”

ChargePoint Technology’s solutions also include its AseptiSafe range of SBVs, designed to increase sterility assurance for ingredient and small component transfers in aseptic processing.

All of ChargePoint Technology’s transfer solutions are independently performance tested to the ISPE SMEPAC guidelines. The company works with select material handling solution partners globally to ensure an integrated high containment handling process is successfully achieved.

Read More

Related news

Pharmapack Europe 2019 Award Winners

Pharmapack Europe 2019 Award Winners

7 Feb 2019

Awards showcased a wide range of industry-changing discoveries in drug delivery, packaging and automation.

Read more 
Brexit - the EU FMD's painful problem

Brexit - the EU FMD's painful problem

7 Feb 2019

Teething problems are no stranger to the implementation of new regulations, but with the EU FMD, Brexit came like a set of wisdom teeth – late, painful and problematic.

Read more 
New series of advanced freeze dryers

New series of advanced freeze dryers

6 Feb 2019

The LyoConstellation series allows the development of highly aggressive cycles and the mapping of the furthest reaches of theoretical design space for a formulation.

Read more 
Hitachi Chemical to acquire apceth Biopharma

Hitachi Chemical to acquire apceth Biopharma

5 Feb 2019

Acquisition will strengthen Hitachi's presence in the second-largest cell and gene therapy market in the world.

Read more 
FDA approves first generic Advair Diskus

FDA approves first generic Advair Diskus

4 Feb 2019

Mylan's Wixela Inhub is the first FDA-approved therapeutically equivalent generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for certain patients with asthma or COPD.

Read more 
Sartorius joins the community of the National Institute for Innovation in Manufacturing Biopharmaceuticals

Sartorius joins the community of the National Institute for Innovation in Manufacturing Biopharmaceuticals

3 Feb 2019

Company hopes to contribute substantially to further optimizing and accelerating the current manufacturing processes in the biopharmaceutical industry.

Read more 
Particle Sciences partners with Encube Ethicals to develop novel vaginal rings

Particle Sciences partners with Encube Ethicals to develop novel vaginal rings

31 Jan 2019

The partnership will focus on rings for the administration of existing approved drugs, improving drug effectiveness and patient compliance.

Read more 
Manufacturing consultancy up 150% as life sciences prepare for a digital future

Manufacturing consultancy up 150% as life sciences prepare for a digital future

30 Jan 2019

Increasing appetite for digitised manufacturing and using data to improve GMP manufacturing.

Read more 
SGS expands testing capabilities at its Glasgow facility

SGS expands testing capabilities at its Glasgow facility

29 Jan 2019

Clients will benefit from a fully comprehensive range of validated biosafety methods to support cell bank and viral vaccine manufacturing and lot release of drug product.

Read more 
UK and Russia sign MoU on regulatory co-operation on medicines

UK and Russia sign MoU on regulatory co-operation on medicines

29 Jan 2019

Medicines regulators of the UK and Russian set out key principles to support their collaboration on improving public health.

Read more